(Q44773696)

6 December 2017

Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users (English)

1 reference

population-based cohort study

6 December 2017

1 reference

1 reference

4

1 reference

6 December 2017

6

1 reference

6 December 2017

Loes M Hollestein

1

0 references

author name string

Myrthe P P van Herk-Sukel

2

1 reference

6 December 2017

Rikje Ruiter

3

1 reference

6 December 2017

Ron H J Mathijssen

5

1 reference

6 December 2017

Theo Stijnen

7

1 reference

6 December 2017

Jan-Willem W Coebergh

8

1 reference

6 December 2017

Valery E P P Lemmens

9

1 reference

6 December 2017

Ron M C Herings

10

1 reference

6 December 2017

Bruno H C Stricker

11

1 reference

6 December 2017

Tamar Nijsten

12

1 reference

6 December 2017

language of work or name

English

0 references

publication date

9 December 2013

1 reference

International Journal of Cancer

6 December 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 December 2017

135

1 reference

6 December 2017

1

1 reference

6 December 2017

157-165

1 reference

Aspirin and cancer risk: a quantitative review to 2011.

6 December 2017

1 reference

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

21 January 2018

1 reference

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

21 January 2018

1 reference

Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study

21 January 2018

1 reference

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

21 January 2018

1 reference

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

21 January 2018

1 reference

Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study

21 January 2018

1 reference

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome

21 January 2018

1 reference

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

21 January 2018

1 reference

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial

21 January 2018

1 reference

Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials

21 January 2018

1 reference

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

21 January 2018

1 reference

Immortal time bias in pharmaco-epidemiology

21 January 2018

1 reference

An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation

21 January 2018

1 reference

Using prescription claims data for drugs available over-the-counter (OTC).

21 January 2018

1 reference

Insulin analogues and cancer risk: the emergence of second-generation studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28634

1 reference

6 December 2017

1 reference